| Literature DB >> 27718471 |
Mija Ahn1, Pethaiah Gunasekaran2, Ganesan Rajasekaran3, Eun Young Kim3, Soo-Jae Lee4, Geul Bang5, Kun Cho5, Jae-Kyung Hyun6, Hyun-Ju Lee7, Young Ho Jeon8, Nam-Hyung Kim2, Eun Kyoung Ryu9, Song Yub Shin10, Jeong Kyu Bang11.
Abstract
In this study, we report on the first chemical synthesis of ultra-short pyrazole-arginine based antimicrobial peptidomimetics derived from the newly synthesized N-alkyl/aryl pyrazole amino acids. Through the systematic tuning of hydrophobicity, charge, and peptide length, we identified the shortest peptide Py11 with the most potent antimicrobial activity. Py11 displayed greater antimicrobial activity against antibiotic-resistant bacteria, including MRSA, MDRPA, and VREF, which was approximately 2-4 times higher than that of melittin. Besides its higher selectivity (therapeutic index) toward bacterial cells than LL-37, Py11 showed highly increased proteolytic stability against trypsin digestion and maintained its antimicrobial activity in the presence of physiological salts. Interestingly, Py11 exhibited higher anti-biofilm activity against MDRPA compared to LL-37. The results from fluorescence spectroscopy and transmission electron microscopy (TEM) suggested that Py11 kills bacterial cells possibly by integrity disruption damaging the cell membrane, leading to the cytosol leakage and eventual cell lysis. Furthermore, Py11 displayed significant anti-inflammatory (endotoxin-neutralizing) activity by inhibiting LPS-induced production of nitric oxide (NO) and TNF-α. Collectively, our results suggest that Py11 may serve as a model compound for the design of antimicrobial and antisepsis agents. Copyright ÂEntities:
Keywords: Anti-biofilm activity; Antimicrobial activity; Bacterial killing mechanism; Pyrazole-derived amino acids; Ultra-short peptidomimetics
Mesh:
Substances:
Year: 2016 PMID: 27718471 DOI: 10.1016/j.ejmech.2016.09.071
Source DB: PubMed Journal: Eur J Med Chem ISSN: 0223-5234 Impact factor: 6.514